HMPV and RSV are common respiratory illnesses that can often cause similar symptoms However it is crucial to differentiate ...

InflaRx (NASDAQ:IFRX) has received EU regulatory approval for its treatment Gohibic for the treatment of COVID-19 patients ...

During cold and flu season, it can be challenging to differentiate illnesses like the common cold, flu, COVID-19, respiratory ...

LEXINGTON, Ky. — Kentucky is seeing a “very high” rate of respiratory illness, especially among children. “We are seeing ...

Workshop on Yogic Management of Respiratory Disorders held at MDNIY in New Delhi: Our Bureau, Chennai Saturday, January 25, 2025, 08:00 Hrs [IST] A special workshop on ‘Yogic Ma ...

InflaRx receives European marketing authorization for Gohibicto treat of SARS-CoV-2-induced acute respiratory distress syndrome: Jena, Germany Friday, January 17, 2025, 11:00 Hrs ...

This is a retrospective study of the history, roentgenology and autopsy pathology when appropriate of all infants with severe respiratory-distress syndrome who required twenty-four hours or more ...

InflaRx (IFRX) announced that the European Commission has granted marketing authorization under exceptional circumstances for Gohibic for the ...